この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1997/7/81 分で読めます
Medtronic, Inc.; Premarket Approval of the CapSureRegister Epi Pacing Lead, Model 4965
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing its approval of the application submitted by Medtronic, Inc., Minneapolis, MN, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the CapSure Epi Pacing Lead, Model 4965. After reviewing the recommendation of the Circulatory System Devices Panel, FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of September 6, 1996, of the approval of the application.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →